Display options
Cite
Mamedov T, Yuksel D, Ilgın M, et al. Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in . Vaccines (Basel). 2021;9(11)doi: 10.3390/vaccines9111337.
Mamedov, T., Yuksel, D., Ilgın, M., Gürbüzaslan, I., Gulec, B., Mammadova, G., Ozdarendeli, A., Yetiskin, H., Kaplan, B., Islam Pavel, S. T., Uygut, M. A., & Hasanova, G. (2021). Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in . Vaccines, 9(11), . https://doi.org/10.3390/vaccines9111337
Mamedov, Tarlan, et al. "Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in ." Vaccines vol. 9,11 (2021). doi: https://doi.org/10.3390/vaccines9111337
Mamedov T, Yuksel D, Ilgın M, Gürbüzaslan I, Gulec B, Mammadova G, Ozdarendeli A, Yetiskin H, Kaplan B, Islam Pavel ST, Uygut MA, Hasanova G. Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in . Vaccines (Basel). 2021 Nov 17;9(11). doi: 10.3390/vaccines9111337. PMID: 34835268; PMCID: PMC8621474.
Copy Download .nbib Format: NLM
Share it on

Vaccines (Basel). 2021 Nov 17;9(11). doi: 10.3390/vaccines9111337.

Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in .

Vaccines

Tarlan Mamedov, Damla Yuksel, Merve Ilgın, Irem Gürbüzaslan, Burcu Gulec, Gulshan Mammadova, Aykut Ozdarendeli, Hazel Yetiskin, Busra Kaplan, Shaikh Terkis Islam Pavel, Muhammet Ali Uygut, Gulnara Hasanova

Affiliations

  1. Department of Agricultural Biotechnology, Akdeniz University, Antalya 07058, Turkey.
  2. Department of Microbiology, Medical Faculty, Erciyes University, Kayseri 38280, Turkey.
  3. Vaccine Research, Development and Application Center, Erciyes University, Kayseri 38280, Turkey.

PMID: 34835268 PMCID: PMC8621474 DOI: 10.3390/vaccines9111337

Abstract

The COVID-19 pandemic has put global public health at high risk, rapidly spreading around the world. Although several COVID-19 vaccines are available for mass immunization, the world still urgently needs highly effective, reliable, cost-effective, and safe SARS-CoV-2 coronavirus vaccines, as well as antiviral and therapeutic drugs, to control the COVID-19 pandemic given the emerging variant strains of the virus. Recently, we successfully produced receptor-binding domain (RBD) variants in the

Keywords: COVID-19; RBD of SARS-CoV-2; SARS-CoV-2; nucleocapsid protein; plant; transient expression system

References

  1. Plant Biotechnol J. 2015 Oct;13(8):1136-59 - PubMed
  2. N Engl J Med. 2020 Nov 12;383(20):1920-1931 - PubMed
  3. Front Plant Sci. 2021 May 13;12:682953 - PubMed
  4. J Biol Regul Homeost Agents. 2021 Jul 07;35(3):843-846 - PubMed
  5. N Engl J Med. 2003 May 15;348(20):1967-76 - PubMed
  6. J Virol. 2006 Jun;80(12):5757-67 - PubMed
  7. Science. 2021 Apr 9;372(6538): - PubMed
  8. Cell Host Microbe. 2021 Jan 13;29(1):23-31.e4 - PubMed
  9. Viruses. 2021 Aug 12;13(8): - PubMed
  10. J Clin Microbiol. 2020 May 26;58(6): - PubMed
  11. Science. 2003 May 30;300(5624):1394-9 - PubMed
  12. J Virol. 2020 Jun 16;94(13): - PubMed
  13. Science. 2020 Mar 13;367(6483):1260-1263 - PubMed
  14. Plants (Basel). 2020 Jul 04;9(7): - PubMed
  15. Sci Rep. 2019 Jul 8;9(1):9868 - PubMed
  16. Science. 2021 Feb 19;371(6531):850-854 - PubMed
  17. Adv Protein Chem Struct Biol. 2015;99:55-74 - PubMed
  18. Nature. 2020 Oct;586(7830):578-582 - PubMed
  19. Lancet. 2020 Aug 15;396(10249):467-478 - PubMed
  20. Science. 2020 Oct 30;370(6516):564-570 - PubMed
  21. JAMA. 2021 Mar 16;325(11):1037-1038 - PubMed
  22. Nat Med. 2021 Apr;27(4):622-625 - PubMed
  23. PLoS One. 2019 Mar 12;14(3):e0213438 - PubMed
  24. Vaccine. 2009 Aug 6;27(36):5001-7 - PubMed
  25. J Infect Dis. 2004 Jul 15;190(2):379-86 - PubMed
  26. J Virol. 2020 Jan 31;94(4): - PubMed
  27. Plants (Basel). 2019 Dec 01;8(12): - PubMed
  28. Cell. 2020 Aug 20;182(4):812-827.e19 - PubMed
  29. Acta Pharm Sin B. 2020 Jul;10(7):1228-1238 - PubMed
  30. J Chem Inf Model. 2021 Nov 22;: - PubMed
  31. J Virol. 2020 Mar 17;94(7): - PubMed
  32. J Biol Regul Homeost Agents. 2021 Jun 09;35(3):839-842 - PubMed
  33. Science. 2003 May 30;300(5624):1377-8 - PubMed
  34. Virus Evol. 2020 Aug 19;6(2):veaa061 - PubMed
  35. Nature. 2021 Aug;596(7871):276-280 - PubMed
  36. Lancet. 2020 Jun 13;395(10240):1845-1854 - PubMed
  37. Cell. 2020 Sep 3;182(5):1295-1310.e20 - PubMed
  38. Cell Host Microbe. 2020 Apr 8;27(4):671-680.e2 - PubMed
  39. PLoS One. 2016 Apr 21;11(4):e0153956 - PubMed
  40. Nat Commun. 2020 May 20;11(1):2601 - PubMed
  41. Front Plant Sci. 2021 Jun 15;12:689104 - PubMed
  42. Plant Biotechnol J. 2009 Sep;7(7):682-93 - PubMed
  43. PLoS One. 2020 Sep 16;15(9):e0238614 - PubMed
  44. Cell. 2020 Oct 29;183(3):739-751.e8 - PubMed
  45. BMC Microbiol. 2021 Feb 22;21(1):58 - PubMed
  46. Cell. 2020 Nov 12;183(4):1024-1042.e21 - PubMed
  47. Vaccines (Basel). 2021 Sep 06;9(9): - PubMed
  48. Mol Biotechnol. 2015 Feb;57(2):101-10 - PubMed
  49. Science. 2020 Dec 18;370(6523):1464-1468 - PubMed
  50. PLoS One. 2017 Aug 21;12(8):e0183589 - PubMed
  51. N Engl J Med. 2020 Dec 17;383(25):2439-2450 - PubMed

Publication Types

Grant support